Search - tctmd.com

Displaying 121 - 140 of 829

Sort: Relevancy | Date

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

L.A. McKeown

December 09, 2024

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Daily News

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Todd Neale

November 28, 2024

News Daily News

CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs

Todd Neale

November 27, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Daily News

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

Yael L. Maxwell

November 15, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

Presentation TCT 2024

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

Presenter: Chun-Wei Lee

October 29, 2024

Presentation TCT 2024

TCT 811: Overweight and Obesity Have the Lowest Mortality Whereas Cachexia Has the Highest Inpatient Mortality Followed by Morbid Obesity in Patients Presenting With ST-Elevation Myocardial Infarction

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

Diabetes and Obesity: Modulating Cardiometabolic Risks

Presenter: C. Michael Gibson

October 28, 2024

Presentation TCT 2024

TCT 459: Lack of Obesity Paradox Regarding Mortality in Patients Undergoing Extracorporeal Membrane Oxygenation Treatment

Presenter: Mohammad Reza Movahed

October 27, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

Advertisement

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

TCTMD’s Top 10 Most Popular Stories for November 2024

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs

November 2024 Dispatch for the CV Team

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

TCT 811: Overweight and Obesity Have the Lowest Mortality Whereas Cachexia Has the Highest Inpatient Mortality Followed by Morbid Obesity in Patients Presenting With ST-Elevation Myocardial Infarction

TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI

Diabetes and Obesity: Modulating Cardiometabolic Risks

TCT 459: Lack of Obesity Paradox Regarding Mortality in Patients Undergoing Extracorporeal Membrane Oxygenation Treatment

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content